Structure of prescription of gastroprotective drugs in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study
- Authors: Ostroumova O.D.1,2, Orlova I.Y.1,3, Kochetkov A.I1, Polyakova O.A1, Listratov A.I2, Shatalova N.A1, Batyukina S.V1
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- Sechenov University
- E.O. Mukhin Municipal Clinical Hospital
- Issue: Vol 29, No 13 (2022)
- Pages: 62-69
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/321132
- DOI: https://doi.org/10.18565/pharmateca.2022.13.62-69
- ID: 321132
Cite item
Abstract
Full Text
About the authors
Olga D. Ostroumova
Russian Medical Academy of Continuous Professional Education; Sechenov University
Email: ostroumova.olga@mail.ru
Dr. Sci. (Med.), Professor, Head of the Department of Therapy and Polymorbid Pathology n.a. Academician M.S. Vovsi; Professor Chair of Clinical Pharmacology and Propaedeutics of Internal Medicine Moscow, Russia
I. Yu Orlova
Russian Medical Academy of Continuous Professional Education; E.O. Mukhin Municipal Clinical HospitalMoscow, Russia
A. I Kochetkov
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
O. A Polyakova
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
A. I Listratov
Sechenov UniversityMoscow, Russia
N. A Shatalova
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
S. V Batyukina
Russian Medical Academy of Continuous Professional EducationMoscow, Russia
References
- Аракелян М.Г, Бокерия Л.А., Васильева Е.Ю. и др. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7):190-260
- Hindricks G, Potpara T, Dagres N., et al., ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. doi: 10.1093/eurheartj/ehaa612
- Остроумова О.Д., Волкова Е.А., Кочетков А.И. и др. Профилактика желудочно-кишечных кровотечений у пациентов, получающих перо-ральные антикоагулянты: фокус на ингибиторы протонной помпы. Кардиоваскулярная терапия и профилактика. 2019;18(5):128-37
- Ruff C.T, Giugliano R.P, Braunwald E., et al.Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-62. Doi: 10.1016/ S0140-6736(13)62343-0
- Holster I.L., Hunfeld N.G., Kuipers E.J., et al. On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage. J Gastrointestin Liver Dis. 2013;22(2):229-31
- Holster I.L., Valkhoff V.E., Kuipers E.J., Tjwa E.T.T.L. New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterol. 2013;145(1):105 12.e15. doi: 10.1053/j.gastro.2013.02.041
- Coleman C.I, Sobieraj D.M., Winkler S., et al. Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.Int J Clin Pract. 2012;66(1):53-63. doi: 10.1111/j.1742-1241.2011.02809.x
- Lauffenburger J.C., Rhoney D.H., Farley J.F., et al. Predictors ofgastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy. Pharmacother. 2015;35(6):560-68. doi: 10.1002/phar.1597
- Steffel J, Verhamme P, Potpara T.S., et al., ESC Scientific Document Group. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330-93. doi: 10.1093/eurheartj/ehy136.
- Naito Y, Yoshikawa T. Rebamipide: a gastrointestinal protective drug with pleiotropic activities. Expert Rev Gastroenterol Hepatol. 2010;4(3):261-70. doi: 10.1586/egh.10.25.
- Lai Y, Zhong W., Yu T, et al. Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of Catenin. PLoS One. 2015;10(7):e0132031. Doi: 10.1371/ journal.pone.0132031.
- Симаненков В.И., Маев И.В., Ткачева О.Н. и др. Синдром повышенной эпителиальной проницаемости в клинической практике. Мультидисциплинарный национальный консенсус. Кардиоваскулярная терапия и профилактика. 2021;20(1):121-28
- Watanabe T., Takeuchi T., Handa O., et al. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage. PLoS One. 2015;10(4):e0122330. doi: 10.1371/journal. pone.0122330
- Pittayanon R., Piyachaturawat P, Rerknimitr R., et al. Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial. J Gastroenterol Hepatol. 2019;34(9):1517-22. doi: 10.1111/jgh.14671.
- Yamashita T., Watanabe E., Ikeda T., et al. Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation. J Arrhythm. 2014;30(6):478-84. Doi: 10.1016/j. joa.2014.02.011.
- Консенсус экспертов по снижению риска желудочно-кишечных кровотечений у пациентов, получающих оральные антикоагулянты. Терапия. 2021;10:23-41.
- Дронова Ю.М., Белесикова В.В. Анализ обоснованности назначения ингибиторов протонной помпы у больных с ишемической болезнью серд -ца, получающих низкие дозы ацетилсалициловой кислоты. Кардиоваскулярная терапия и профилактика. 2022; 21(Suppl. 2):92
- Шахматова О.О., Комаров А.Л., Коробкова В.В. и др. Кровотечения из верхних отделов желудочно-кишечного тракта у пациентов со стабильной ишемической болезнью сердца (по результатам проспективного РЕГистра длительной Антитромботической ТерАпии - РЕГАТА). Терапевтический архив. 2020;92(9):30-8 doi: 10.26442/00403660.2020.09.000699.
- Стабильная ишемическая болезнь сердца. Клинические рекомендации 2020. Рос. кардиологический журнал. 2020;25(11):201-50 doi: 10.15829/1560-4071-2020-4076.
- Liu Y., Zhu X., Li R., Zhang J., et al. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ. Open. 2020;10(11):e040473. Doi: 10.1136/ bmjopen-2020-040473